Excision versus colorectal resection in deep endometriosis infiltrating the rectum: 5-year follow-up of patients enrolled in a randomized controlled trial.


Journal

Human reproduction (Oxford, England)
ISSN: 1460-2350
Titre abrégé: Hum Reprod
Pays: England
ID NLM: 8701199

Informations de publication

Date de publication:
01 12 2019
Historique:
received: 10 06 2019
revised: 04 09 2019
accepted: 11 09 2019
pubmed: 11 12 2019
medline: 9 9 2020
entrez: 11 12 2019
Statut: ppublish

Résumé

Is there a difference in functional outcomes and recurrence rate between conservative versus radical rectal surgery in patients with large deep endometriosis infiltrating the rectum 5 years postoperatively? No evidence was found that long-term outcomes differed when nodule excision was compared to rectal resection for deeply invasive endometriosis involving the bowel. Functional outcomes of nodule excision and rectal resection for deeply invasive endometriosis involving the bowel are comparable 2 years after surgery. Despite numerous previously reported case series enrolling patients managed for colorectal endometriosis, long-term data remain scarce in the literature. From March 2011 to August 2013, we performed a two-arm randomized trial, enrolling 60 patients with deep endometriosis infiltrating the rectum up to 15 cm from the anus, measuring >20 mm in length, involving at least the muscular layer in depth, and up to 50% of rectal circumference. Among them, 55 women were enrolled at one tertial referral centre in endometriosis, using a randomization list drawn up separately for this centre. Institute review board approval was obtained to continue follow-up to 10 years postoperatively. One patient requested to stop the follow-up 2 years after surgery. Patients underwent either nodule excision by shaving or disc excision, or segmental resection. Randomization was performed preoperatively using sequentially numbered, opaque, sealed envelopes, and patients were informed of randomization results. The primary endpoint was the proportion of patients experiencing one of the following symptoms: constipation (1 stool/>5 consecutive days), frequent bowel movements (≥3 stools/day), anal incontinence, dysuria or bladder atony requiring self-catheterization 24 months postoperatively. Secondary endpoints were values taken from the Knowles-Eccersley-Scott-symptom questionnaire (KESS), the gastrointestinal quality of life index (GIQLI), the Wexner scale, the urinary symptom profile (USP) and the Short Form 36 Health Survey (SF36). Fifty-five patients were enrolled. Among the 27 patients in the excision arm, two were converted to segmental resection (7.4%). One patient managed by segmental resection withdrew from the study 2 years postoperatively, presuming that associated pain of other aetiologies may have jeopardized the outcomes. The 5 year-recurrence rate for excision and resection was 3.7% versus 0% (P = 1), respectively. For excision and resection, the primary endpoint was present in 44.4% versus 60.7% of patients (P = 0.29), respectively, while 55.6% versus 53.6% of patients subjectively reported normal bowel movements (P = 1). An intention-to-treat comparison of overall KESS, GIQLI, Wexner, USP and SF36 scores did not reveal significant differences between the two arms 5 years postoperatively. Statistically significant improvement was observed shortly after surgery with no further improvement or impairment recorded 1-5 years postoperatively. During the 5-year follow-up, additional surgical procedures were performed in 25.9% versus 28.6% of patients who had undergone excision or resection (P = 0.80), respectively. The presumption of a 40% difference concerning postoperative functional outcomes in favour of nodule excision resulted in a lack of power for demonstration of the primary endpoint difference. Five-year follow-up data do not show statistically significant differences between conservative and radical rectal surgery for long-term functional digestive and urinary outcomes in this specific population of women with large involvement of the rectum. No specific funding was received. Patient enrolment and follow-up until 2 years postoperatively was supported by a grant from the clinical research programme for hospitals in France. The authors declare no competing interests related to this study. This randomized study is registered with ClinicalTrials.gov, number NCT01291576. 31 January 2011. 7 March 2011.

Identifiants

pubmed: 31820806
pii: 5625885
doi: 10.1093/humrep/dez217
pmc: PMC6936722
doi:

Banques de données

ClinicalTrials.gov
['NCT01291576']

Types de publication

Comparative Study Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2362-2371

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For permissions, please e-mail: journals.permission@oup.com.

Références

Am J Obstet Gynecol. 2016 Dec;215(6):762.e1-762.e9
pubmed: 27393269
Dis Colon Rectum. 2000 Oct;43(10):1419-26
pubmed: 11052520
Hum Reprod Update. 2011 May-Jun;17(3):311-26
pubmed: 21233128
Br J Surg. 2000 Jan;87(1):110-5
pubmed: 10606921
BMJ. 1992 Jul 18;305(6846):160-4
pubmed: 1285753
Surg Endosc. 2012 Jul;26(7):2029-45
pubmed: 22278102
Fertil Steril. 2018 Jan;109(1):172-178.e1
pubmed: 29307394
Hum Reprod. 2010 Aug;25(8):1949-58
pubmed: 20547557
Eur J Obstet Gynecol Reprod Biol. 2019 Jan;232:46-53
pubmed: 30468983
Hum Reprod. 2018 Mar 1;33(3):411-415
pubmed: 29315418
Fertil Steril. 2013 Nov;100(5):e33
pubmed: 23932024
Fertil Steril. 2017 Dec;108(6):931-942
pubmed: 29202966
J Gynecol Obstet Hum Reprod. 2019 Oct;48(8):625-629
pubmed: 30902761
Dis Colon Rectum. 2018 Feb;61(2):221-229
pubmed: 29337778
Fertil Steril. 2013 May;99(6):1695-704
pubmed: 23465818
J Minim Invasive Gynecol. 2016 Nov - Dec;23(7):1123-1129
pubmed: 27544881
J Minim Invasive Gynecol. 2018 Jan;25(1):139-146
pubmed: 28893658
Semin Reprod Med. 2017 Jan;35(1):72-80
pubmed: 27951614
Hum Reprod Update. 2015 May-Jun;21(3):329-39
pubmed: 25618908
Hum Reprod. 2018 Sep 1;33(9):1669-1676
pubmed: 30052994
BJOG. 2016 Jul;123(8):1368
pubmed: 27095062
Dis Colon Rectum. 1993 Jan;36(1):77-97
pubmed: 8416784
Dis Colon Rectum. 2018 Jun;61(6):733-742
pubmed: 29664797
Fertil Steril. 2017 Apr;107(4):977-986.e2
pubmed: 28139235
Hum Reprod. 2018 Jan 1;33(1):47-57
pubmed: 29194531
J Minim Invasive Gynecol. 2016 Jul-Aug;23(5):753-9
pubmed: 26976198
BJOG. 2016 Jul;123(8):1360-7
pubmed: 26956803
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542
Fertil Steril. 2010 Jul;94(2):444-9
pubmed: 19394600
Urology. 2008 Apr;71(4):646-56
pubmed: 18313122

Auteurs

Horace Roman (H)

Endometriosis Center, Clinique Tivoli-Ducos, Bordeaux 33000, France.
Department of Obstetrics and Gynecology, Aarhus University Hospital, Aarhus, Denmark.

Jean-Jacques Tuech (JJ)

Department of Surgery, Rouen University Hospital, Rouen 76031, France.

Emmanuel Huet (E)

Department of Surgery, Rouen University Hospital, Rouen 76031, France.

Valérie Bridoux (V)

Department of Surgery, Rouen University Hospital, Rouen 76031, France.

Haitham Khalil (H)

Department of Surgery, Rouen University Hospital, Rouen 76031, France.

Clotilde Hennetier (C)

Expert Center in the Diagnosis and Multidisciplinary Management of Endometriosis, Rouen University Hospital, Rouen 76031, France.

Michael Bubenheim (M)

Department of Biostatistics, Rouen University Hospital, Rouen 76031, France.

Lacramioara Aurelia Branduse (LA)

Department of Public Health and Management, Carol Davila University of Medicine and Pharmacy Bucharest, Romania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH